Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients, Cardiovascular Drugs and Therapy, May 2004, Springer Science + Business Media,
DOI: 10.1023/b:card.0000033644.91126.f7.
You can read the full text:

Read

Contributors

The following have contributed to this page